Ubs Group Ag Avid Bioservices, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 794,861 shares of CDMO stock, worth $9.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

794,861

Previous 185,438 328.64%

Holding current value

$9.93 Million

Previous $2.11 Million 365.21%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$9.96 - $12.36 $6.07 Million - $7.53 Million	609,423 Added 328.64%	794,861 $9.82 Million
Q3 2024 Nov 14, 2024	BUY	$6.7 - $12.45 $53,713 - $99,811	8,017 Added 4.52%	185,438 $2.11 Million
Q2 2024 Aug 13, 2024	SELL	$6.34 - $9.28 $945,896 - $1.38 Million	-149,195 Reduced 45.68%	177,421 $1.27 Million
Q1 2024 May 13, 2024	BUY	$5.86 - $8.79 $384,169 - $576,254	65,558 Added 25.11%	326,616 $2.19 Million
Q4 2023 Feb 09, 2024	BUY	$4.64 - $9.56 $960,498 - $1.98 Million	207,004 Added 382.96%	261,058 $1.7 Million
Q3 2023 Nov 09, 2023	SELL	$9.4 - $14.04 $306,505 - $457,802	-32,607 Reduced 37.63%	54,054 $510,000
Q2 2023 Aug 11, 2023	BUY	$12.96 - $20.93 $145,113 - $234,353	11,197 Added 14.84%	86,661 $1.21 Million
Q1 2023 May 12, 2023	SELL	$13.48 - $18.79 $1.73 Million - $2.41 Million	-128,073 Reduced 62.92%	75,464 $1.42 Million
Q4 2022 Feb 08, 2023	BUY	$12.61 - $18.74 $2.26 Million - $3.35 Million	178,974 Added 728.63%	203,537 $2.8 Million
Q3 2022 Nov 10, 2022	SELL	$15.33 - $20.36 $201,114 - $267,102	-13,119 Reduced 34.82%	24,563 $470,000
Q2 2022 Aug 10, 2022	SELL	$11.63 - $21.55 $1.98 Million - $3.67 Million	-170,262 Reduced 81.88%	37,682 $575,000
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $791,005 - $1.32 Million	47,565 Added 29.66%	207,944 $4.24 Million
Q4 2021 Feb 14, 2022	BUY	$20.7 - $34.18 $566,869 - $936,019	27,385 Added 20.59%	160,379 $4.68 Million
Q3 2021 Nov 15, 2021	BUY	$19.05 - $28.32 $1.09 Million - $1.63 Million	57,420 Added 75.98%	132,994 $2.87 Million
Q2 2021 Aug 13, 2021	BUY	$18.93 - $25.65 $831,462 - $1.13 Million	43,923 Added 138.77%	75,574 $1.94 Million
Q1 2021 May 12, 2021	BUY	$11.86 - $21.77 $275,080 - $504,933	23,194 Added 274.26%	31,651 $577,000
Q4 2020 Feb 11, 2021	BUY	$7.25 - $11.76 $61,313 - $99,454	8,457 New	8,457 $98,000
Q3 2020 Nov 12, 2020	SELL	$6.53 - $8.6 $116,573 - $153,527	-17,852 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$4.11 - $6.78 $65,435 - $107,944	-15,921 Reduced 47.14%	17,852 $117,000
Q1 2020 May 01, 2020	SELL	$3.15 - $7.39 $122,242 - $286,783	-38,807 Reduced 53.47%	33,773 $173,000
Q4 2019 Feb 14, 2020	BUY	$5.01 - $8.16 $190,014 - $309,484	37,927 Added 109.45%	72,580 $557,000
Q3 2019 Nov 14, 2019	BUY	$5.07 - $7.08 $81,697 - $114,087	16,114 Added 86.92%	34,653 $184,000
Q2 2019 Aug 14, 2019	BUY	$3.43 - $5.6 $28,016 - $45,740	8,168 Added 78.76%	18,539 $104,000
Q1 2019 May 14, 2019	SELL	$3.56 - $4.82 $97,793 - $132,405	-27,470 Reduced 72.59%	10,371 $44,000
Q4 2018 Feb 14, 2019	BUY	$4.04 - $6.75 $29,908 - $49,970	7,403 Added 24.32%	37,841 $155,000
Q3 2018 Nov 14, 2018	BUY	$4.28 - $7.32 $37,176 - $63,581	8,686 Added 39.93%	30,438 $209,000
Q2 2018 Aug 14, 2018	BUY	$3.1 - $3.93 $58,574 - $74,257	18,895 Added 661.36%	21,752 $86,000
Q1 2018 May 15, 2018	BUY	$2.32 - $4.22 $6,628 - $12,056	2,857 New	2,857 $8,000

Others Institutions Holding CDMO

# of Institutions

209

Shares Held

67.3M

Call Options Held

216K

Put Options Held

4.6K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account